Covid-19

According to a new Sheba study, COVID-19 patients with low free triiodothyronine levels could be at significantly higher risk of requiring mechanical ventilation and mortality.

Complex Double Lung Transplant on a Recovering COVID-19 Patient Completed Successfully at Sheba Medical Center:

Israel Leads the World in Vaccinations and Hopes to Completely Reopen by the End of March. Click Here to Learn More.

An 85% reduction in symptomatic COVID-19 infections among the recipients of the first dose of the Pfizer-BioNTech vaccine is indicated by new Sheba study. Learn more:

Innovative Blood Oxygenation System Could Help Treat COVID-19 Patients Without Requiring Anesthesia. Click Here to Learn More:

Innovative Mini Ultrasound Device Allows Remote Monitoring of Pregnant Women Quarantined Due to COVID-19 at Sheba Medical Center

New Sheba study indicates that non-alcoholic fatty liver disease could increase the risk of COVID-19 mortality.

With COVID-19 patient numbers on the rise around the world, medical facilities are on the brink of being overwhelmed due to a shortage of ventilation…

According to a new Sheba study, the Pfizer-BioNTech COVID-19 vaccine is highly effective: 98% saw a major increase in COVID-19 antibodies. Learn more.